NASDAQ:VERU - Veru Stock Price, Forecast & News

Veru trades on the NASDAQ under the ticker symbol "VERU."

Veru Inc (NASDAQ:VERU) released its quarterly earnings data on Wednesday, February, 12th. The company reported ($0.05) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.03. The firm earned $10.58 million during the quarter, compared to analysts' expectations of $9.30 million. Veru had a negative return on equity of 40.45% and a negative net margin of 36.58%. View Veru's Earnings History.

Veru is scheduled to release their next quarterly earnings announcement on Wednesday, May 20th 2020. View Earnings Estimates for Veru.

5 analysts have issued 12 month price objectives for Veru's shares. Their forecasts range from $5.00 to $12.00. On average, they expect Veru's stock price to reach $6.80 in the next twelve months. This suggests a possible upside of 59.6% from the stock's current price. View Analyst Price Targets for Veru.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veru in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Veru.

News articles about VERU stock have trended somewhat positive recently, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Veru earned a daily sentiment score of 1.5 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Veru.

Veru saw a decrease in short interest in the month of February. As of February 14th, there was short interest totalling 212,900 shares, a decrease of 10.9% from the January 30th total of 238,900 shares. Based on an average daily trading volume, of 357,200 shares, the days-to-cover ratio is currently 0.6 days. Currently, 0.5% of the shares of the company are short sold. View Veru's Current Options Chain.

Some companies that are related to Veru include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Avon Products (AVP), Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), Nu Skin Enterprises (NUS), USANA Health Sciences (USNA), Medifast (MED), Revlon (REV) and Nature's Sunshine Products (NATR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Veru investors own include Corbus Pharmaceuticals (CRBP), Genocea Biosciences (GNCA), Opko Health (OPK), Strongbridge Biopharma (SBBP), Verastem (VSTM), NovaBay Pharmaceuticals (NBY), Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), Viking Therapeutics (VKTX) and Zynerba Pharmaceuticals (ZYNE).

Veru's stock is owned by many different of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (1.39%), Geode Capital Management LLC (0.56%), EAM Investors LLC (0.46%), Wedge Capital Management L L P NC (0.45%), Credit Suisse AG (0.17%) and Raymond James & Associates (0.14%). Company insiders that own Veru stock include Harry Fisch, Jesus Socorro, K Gary Barnette, Michele Greco and Mitchell Shuster Steiner. View Institutional Ownership Trends for Veru.

VERU stock was sold by a variety of institutional investors in the last quarter, including Raymond James & Associates and UBS Group AG. View Insider Buying and Selling for Veru.

VERU stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, EAM Investors LLC, Credit Suisse AG, Wedge Capital Management L L P NC, Geode Capital Management LLC, Goldman Sachs Group Inc., Cubist Systematic Strategies LLC and Alpine Global Management LLC. Company insiders that have bought Veru stock in the last two years include Harry Fisch, Jesus Socorro, K Gary Barnette, Michele Greco and Mitchell Shuster Steiner. View Insider Buying and Selling for Veru.

Shares of VERU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VERU stock can currently be purchased for approximately $4.26.

Veru has a market capitalization of $277.72 million and generates $31.80 million in revenue each year. The company earns $-12,020,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis. Veru employs 171 workers across the globe.View Additional Information About Veru.

The official website for Veru is http://www.veruhealthcare.com/.

Veru's mailing address is 48 NW 25th Street Suite 102, Miami FL, 33127. The company can be reached via phone at 305-509-6897 or via email at [email protected]